Keyphrases
Targeted Therapy
100%
Prognostic Marker
100%
Chronic Lymphocytic Leukemia
100%
Receptor Targets
100%
B Cell Receptor
100%
Risk Factors
42%
Disease Progression
28%
Plasma Parameters
28%
Related Risk Factors
28%
Leukemia Risk
28%
CCL3
28%
Clinical Prognosis
14%
Disease Prognosis
14%
CD38
14%
Clinical Presentation
14%
Traditional Clinical
14%
Disease Risk
14%
Receptor Function
14%
Prognostic Impact
14%
Response Assessment
14%
Immunoglobulin Heavy Chain Gene
14%
PI3K Inhibitor
14%
Expert Opinion
14%
Targeted Agents
14%
Mutational Status
14%
B-cell Malignancies
14%
Receptor-targeted Therapy
14%
Receptor Signaling
14%
Treatment Decisions
14%
ZAP-70 Expression
14%
Area Cover
14%
Patient Identification
14%
Cytogenetic Risk
14%
Syk Kinase
14%
Clinical Staging Model
14%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
B Lymphocyte Receptor
100%
Disease Exacerbation
28%
Cancer
14%
Targeted Therapy
14%
Immunoglobulin Heavy Chain
14%
Kinase
14%
B Cell
14%
Phosphoinositide 3-Kinase Inhibitor
14%
Protein Kinase ZAP 70
14%
Protein Kinase Syk Inhibitor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
B Lymphocyte Receptor
100%
Disease Exacerbation
28%
Phosphatidylinositol 3 Kinase Inhibitor
14%
Immunoglobulin Heavy Chain
14%
Protein Kinase ZAP 70
14%
Protein Kinase Syk Inhibitor
14%